Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

BioSig’s ViralClear to proceed with COVID-19 treatment

Westport medical technology company BioSig Technologies and its majority-owned subsidiary ViralClear Pharmaceuticals have received FDA approval to proceed with a proposed COVID-19 treatment. ViralClear can...

| By Kelley Gipson

Wiggin and Dana: complimentary virtual IP consultations

In response to the COVID-19 pandemic and ongoing social distancing requirements, Wiggin and Dana’s IP Practice group is providing complimentary virtual IP consultations through video and...

| By Kelley Gipson

Rallybio completes $145 million Series B financing

Rallybio has completed a $145 million Series B financing. Proceeds from the financing will be used to advance Rallybio’s current portfolio of product candidates and...

| By Kelley Gipson

UConn wins grants for genomics and ovarian cancer

Researchers at UConn Health and The Jackson Laboratory for Genomic Medicine are collaborating to develop a training program for the next generation of genomic scientists...

| By Kelley Gipson

Sema4 named ‘2020 Cool Vendor’ by Gartner

Sema4 has been named a 2020 Cool Vendor in Healthcare Technology by Gartner Inc., the leading research and advisory company. According to Gartner, “healthcare delivery...

| By Kelley Gipson

CT Innovations invests $14.3M in fiscal Q3

Connecticut Innovations, the state’s venture capital investment arm, reports that investment transactions during the third quarter of its 2020 fiscal year totaled $14.3 million across 39...

| By Kelley Gipson

FDA fosters development of COVID-19 treatments

The FDA says is has taken action to accelerate the development of prevention and treatment options for COVID-19 by providing new guidance with recommendations for...

| By Kelley Gipson

JAX to expand COVID-19 testing capability

The Jackson Laboratory (JAX), in partnership with the State of Connecticut, is expanding its COVID-19 testing capacity from 550 tests per day to 20,000 tests...

| By Kelley Gipson

New Haven eyes biospace construction standards

The New Haven City Plan department has proposed updating the city’s zoning laws to allow for larger developments in exchange for more environmentally friendly construction...